Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease - Test2 - elhamkhani - TriplyDB

Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease

Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease

http://www.wikidata.org/entity/Q36580195

about

Psychostimulants and cognition: a continuum of behavioral and cognitive activation Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks Adenosine receptor signaling: a key to opening the blood-brain door Antioxidants and Dementia Risk: Consideration through a Cerebrovascular Perspective Adenosine receptors as drug targets--what are the challenges?Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.Water Exchange across the Blood-Brain Barrier in Obstructive Sleep Apnea: An MRI Diffusion-Weighted Pseudo-Continuous Arterial Spin Labeling Study.Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy.The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer's disease: an overview of pre-clinical studies and translational perspectives in clinical practice.The effects of cholesterol on learning and memory.Cholesterol and copper affect learning and memory in the rabbit.Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet.Homeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy.Human brain endothelial cells are responsive to adenosine receptor activation.Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.Blood-brain barrier permeability and tPA-mediated neurotoxicity.Role of membrane biophysics in Alzheimer's-related cell pathways.Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process Endolysosome involvement in LDL cholesterol-induced Alzheimer's disease-like pathology in primary cultured neurons.Dietary high cholesterol and trace metals in the drinking water increase levels of ABCA1 in the rabbit hippocampus and temporal cortex Caffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF.Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury.Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice Role of Endolysosomes in Skeletal Muscle Pathology Observed in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease.The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat.Dietary cholesterol increases ventricular volume and narrows cerebrovascular diameter in a rabbit model of Alzheimer's disease.The Immunomodulatory Effects of Plant Extracts and Plant Secondary Metabolites on Chronic Neuroinflammation and Cognitive Aging: A Mechanistic and Empirical Review.Caffeine and the control of cerebral hemodynamics.Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer's disease.Effect of different rhBMP-2 and TG-VEGF ratios on the formation of heterotopic bone and neovessels.Hypercholesterolemia induces short-term spatial memory impairments in mice: up-regulation of acetylcholinesterase activity as an early and causal event?Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.Pathological overproduction: the bad side of adenosine.Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.

P2860

Q22242285-F254868D-292C-4D2A-B02E-07573925E363 Q26740559-5C3257EB-F619-46CE-80E7-8B490335181F Q26795435-41DF08DE-FE9A-419F-A638-EA212D3DC34F Q28067402-8E41F6EC-CCB3-472E-9736-401A1F4015E7 Q29346491-9227125F-8921-47CA-80B6-86DD0451D14A Q30528069-BE57FA3A-8FAC-4A5F-AF62-8BCB45EB2142 Q30991175-37C1750B-F78A-44EA-B08B-81D5C3BED242 Q33584772-6D17C383-0F1E-4BBE-8DAB-539E114DDB0A Q33770621-ADD36AFE-EAE0-48DD-BFA5-B2AEFF93ABA3 Q33814399-67BA4EE8-1FA5-49DA-AE18-96C3610FA8DB Q33976829-93BC4B65-8D94-421F-A874-46B8BEAF98E1 Q34373769-AC63F6C7-AB97-458D-979F-7B69D6A8262A Q34743986-BB9DE26C-F296-42EF-94EA-0D348A66D740 Q34905120-304FF681-3829-4807-B02A-60A58B98AEAA Q34985303-066ED34D-5810-49B2-939E-894F29520BF2 Q35072901-E0A73286-29B2-4A60-A76E-7B94B93C4DD0 Q35136806-DA300FF6-B26D-4ECE-80C3-4EC5C90E46B4 Q35225919-9AF698B0-B415-407F-A7C5-000D67F372D7 Q35489240-64816577-04F7-4D86-8931-55CF73D8A7DC Q35580943-399C5E1F-018D-403E-AEE1-DE7B1742A3B7 Q35650286-58B57F00-1C60-4D5D-AF05-77EC1BC05EF6 Q36062897-8BFAA525-1B87-4DA3-857D-3FF0D10444E1 Q36201070-916E467F-1593-40CB-8A66-9666996FCDF7 Q36275360-51CC7000-D2F6-4CBF-8E59-C4E65E9C1770 Q36650968-684A904D-A477-4B90-87A4-1C473D34215E Q36763899-1B85DAB0-38F1-430D-84C1-9EF0CAF2A8E3 Q36954618-C96059F6-E8CC-4FF2-A6CE-9AC06387DF02 Q36958137-C111BEDD-2B6C-4CFD-B2D5-38C9C687CD21 Q36978700-88A62F5D-6908-4D2A-8CA5-A156F96C9190 Q37156631-7F42C58B-8E33-4222-9F6C-2635EE8A1890 Q37315981-CD2B0A8D-1E30-4752-86AF-359A46B6F133 Q37692206-769378A6-76E8-4026-8A91-E284B7552F0F Q37698068-EE226DAC-F025-4A84-BFF7-31CC2C6963DF Q38414035-A46AB38A-717E-4D74-964E-E8E4DC230CD8 Q38672178-01EE991E-344F-41DA-9B91-E469C7C4FDAF Q38690289-82155FF1-1FAF-4117-97A1-DF4301FD44DB Q39069411-A2A89182-CEC8-4C89-A949-0565AF533E2C Q39157059-8C2E679D-B4F0-4EAF-8196-8FA36B915EB6 Q39157893-5B3DF0E6-A693-409D-94A8-4A547ACCB865 Q42013048-71FD79A9-EBC6-465F-86B9-71BFC298EDE1

P2860

Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease

http://www.wikidata.org/entity/Q36580195

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Caffeine blocks disruption of ...... t model of Alzheimer's disease

@ast

Caffeine blocks disruption of ...... t model of Alzheimer's disease

@en

type

label

Caffeine blocks disruption of ...... t model of Alzheimer's disease

@ast

Caffeine blocks disruption of ...... t model of Alzheimer's disease

@en

prefLabel

Caffeine blocks disruption of ...... t model of Alzheimer's disease

@ast

Caffeine blocks disruption of ...... t model of Alzheimer's disease

@en

P1433

Q36580195-49DF593F-1ED8-42A1-9684-D43B7EBD39CA

P1476

Q36580195-D485024F-F540-4410-9CC5-420CC91D9C2D

P2093

Q36580195-1D1D8D35-A944-422D-B3AB-8566845C93A8

Q36580195-385FF505-2D41-4958-92FF-ADB57666ECCB

Q36580195-5DC11558-22D9-4101-BD42-704869DCC90A

Q36580195-B49D0B67-E92F-4734-A552-D1EF6B630775

Q36580195-D04E0321-AB58-43FB-A355-C4F2BF34CFFA

P2860

Q36580195-00D27F55-F037-4DC8-BAA4-E90F34DC13C6

Q36580195-0EC9E604-8D51-4EE0-929D-78A93C4B62F0

Q36580195-111BF365-1CAA-46A3-ADF3-275D3D4EFCE7

Q36580195-1F58AC51-1776-4FEF-87D4-3A07C4BAA2E8

Q36580195-24EAEFD7-DD3A-49AB-A30A-841A5F662A6D

Q36580195-345AB051-79E4-448D-889F-CD0498E56D41

Q36580195-35FDC207-460C-4F3A-A14E-7D0993C748DE

Q36580195-37C2D021-89FB-4637-893A-35904061E5FF

Q36580195-38BD12A2-5CC2-4085-AB8D-4C9AABDE1050

Q36580195-432FFF88-1BC9-47C4-8695-499DE456B124

P2888

Q36580195-0ECB907E-6A26-42B3-B30C-21C1405C35A5

P304

Q36580195-1C1F7A62-57FD-4207-A07D-2934A934D537

P31

Q36580195-51439644-5818-4DD7-B706-915C8AEB836E

P356

Q36580195-DEDDEF4C-66AC-41F2-8DE4-9C69737BE600

P478

Q36580195-12E5A4D9-FF52-43C4-B4F5-7ADAF92D2249

P577

Q36580195-CF4D78B2-5205-4C8D-B886-B7CADAD7736E

P5875

Q36580195-6A90BE86-B1E2-4E66-93A1-7DB8E3DFF270

P6179

Q36580195-DCC8820F-352F-4047-A273-FE3661D7E4B5

P698

Q36580195-56A75E09-FD74-4F93-B021-2350F82E74EE

P921

Q36580195-B4D45A3E-E88B-4508-AFCE-913E8F7E0807

Q36580195-F7674A96-B2EB-4403-AF99-1EE9375B7D7F

P932

Q36580195-1C09075E-D005-4FD7-8743-EEE0829C74A2

P356

P1433

Journal of Neuroinflammation

P1476

Caffeine blocks disruption of ...... t model of Alzheimer's disease

@en

P2093

Jeremy W Gawryluk

http://www.w3.org/2001/XMLSchema#string

John F Wagener

http://www.w3.org/2001/XMLSchema#string

Jonathan D Geiger

http://www.w3.org/2001/XMLSchema#string

Othman Ghribi

http://www.w3.org/2001/XMLSchema#string

Xuesong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

Astrocyte-endothelial interactions at the blood-brain barrier

Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction

Vascular-specific growth factors and blood vessel formation

The blood-brain barrier/neurovascular unit in health and disease

The blood-brain barrier in health and chronic neurodegenerative disorders

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

Brain-specific src oncogene mRNA mapped in rat brain by in situ hybridization.

Is cholesterol a risk factor for stroke?: Yes.

P2888

P304

12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-2094-5-12

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5465729

http://www.w3.org/2001/XMLSchema#string

P6179

1026540813

http://www.w3.org/2001/XMLSchema#string

P698

18387175

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

blood–brain barrier

P932

2330033

http://www.w3.org/2001/XMLSchema#string